These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16342291)

  • 21. Suicidality with selective serotonin reuptake inhibitors: Valid claim?
    Lapierre YD
    J Psychiatry Neurosci; 2003 Sep; 28(5):340-7. PubMed ID: 14517577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
    Weller EB; Tucker S; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants and suicide attempts in children.
    Cooper WO; Callahan ST; Shintani A; Fuchs DC; Shelton RC; Dudley JA; Graves AJ; Ray WA
    Pediatrics; 2014 Feb; 133(2):204-10. PubMed ID: 24394688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressants and suicide: risk-benefit conundrums.
    Healy D; Whitaker C
    J Psychiatry Neurosci; 2003 Sep; 28(5):331-7. PubMed ID: 14517576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facing the evidence: antidepressant treatment in children and adolescents.
    Garland EJ
    CMAJ; 2004 Feb; 170(4):489-91. PubMed ID: 14970097
    [No Abstract]   [Full Text] [Related]  

  • 27. Antidepressants and suicide risk in the United States, 1985-1999.
    Grunebaum MF; Ellis SP; Li S; Oquendo MA; Mann JJ
    J Clin Psychiatry; 2004 Nov; 65(11):1456-62. PubMed ID: 15554756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.
    Khan A; Khan S; Kolts R; Brown WA
    Am J Psychiatry; 2003 Apr; 160(4):790-2. PubMed ID: 12668373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suicidal risk from TADS study was higher than it first appeared.
    Högberg G; Antonuccio DO; Healy D
    Int J Risk Saf Med; 2015; 27(2):85-91. PubMed ID: 26410011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Schneeweiss S; Patrick AR; Solomon DH; Mehta J; Dormuth C; Miller M; Lee JC; Wang PS
    Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants and suicidality: the basis of controversies.
    Marcinko D
    Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on antidepressant use and suicidality in pediatric depression.
    Adegbite-Adeniyi C; Gron B; Rowles BM; Demeter CA; Findling RL
    Expert Opin Pharmacother; 2012 Oct; 13(15):2119-30. PubMed ID: 22984934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Youth suicide trends place SSRIs in spotlight.
    Behav Healthc Tomorrow; 2004 Feb; 13(1):42-5. PubMed ID: 15002199
    [No Abstract]   [Full Text] [Related]  

  • 35. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.
    Martinez C; Rietbrock S; Wise L; Ashby D; Chick J; Moseley J; Evans S; Gunnell D
    BMJ; 2005 Feb; 330(7488):389. PubMed ID: 15718538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suicide prevention and serotonergic drugs.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?
    Healy D
    Can J Psychiatry; 2009 Feb; 54(2):69-71; discussion 76-7. PubMed ID: 19254434
    [No Abstract]   [Full Text] [Related]  

  • 38. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall WD; Lucke J
    Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H; Audenaert K; van Heeringen C
    Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.